Emerging data suggest this peptide, a dual activator targeting both the gut-brain axis and another hormone, appears to offer a promising step forward for weight treatment. Preliminary clinical investigations have indicated impressive losses in visceral tissue, possibly surpassing existing weight-loss therapies . Nevertheless , additional study is n